These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32181366)

  • 1. Tethered peptide neurotoxins display two blocking mechanisms in the K
    Zhao R; Dai H; Mendelman N; Chill JH; Goldstein SAN
    Sci Adv; 2020 Mar; 6(10):eaaz3439. PubMed ID: 32181366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer and natural peptide toxin blockers of the KcsA potassium channel identified by phage display.
    Zhao R; Dai H; Mendelman N; Cuello LG; Chill JH; Goldstein SA
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E7013-21. PubMed ID: 26627718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.
    Rauer H; Pennington M; Cahalan M; Chandy KG
    J Biol Chem; 1999 Jul; 274(31):21885-92. PubMed ID: 10419508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
    Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
    FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K
    Sanches K; Prypoten V; Chandy KG; Chalmers DK; Norton RS
    J Chem Inf Model; 2023 May; 63(10):3043-3053. PubMed ID: 37143234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.
    Pennington MW; Lanigan MD; Kalman K; Mahnir VM; Rauer H; McVaugh CT; Behm D; Donaldson D; Chandy KG; Kem WR; Norton RS
    Biochemistry; 1999 Nov; 38(44):14549-58. PubMed ID: 10545177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KcsA-Kv1.x chimeras with complete ligand-binding sites provide improved predictivity for screening selective Kv1.x blockers.
    Szekér P; Bodó T; Klima K; Csóti Á; Hanh NN; Murányi J; Hajdara A; Szántó TG; Panyi G; Megyeri M; Péterfi Z; Farkas S; Gyöngyösi N; Hornyák P
    J Biol Chem; 2024 Apr; 300(4):107155. PubMed ID: 38479597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, folding and stability of a minimal homologue from Anemonia sulcata of the sea anemone potassium channel blocker ShK.
    Krishnarjuna B; MacRaild CA; Sunanda P; Morales RAV; Peigneur S; Macrander J; Yu HH; Daly M; Raghothama S; Dhawan V; Chauhan S; Tytgat J; Pennington MW; Norton RS
    Peptides; 2018 Jan; 99():169-178. PubMed ID: 28993277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR.
    Lange A; Giller K; Hornig S; Martin-Eauclaire MF; Pongs O; Becker S; Baldus M
    Nature; 2006 Apr; 440(7086):959-62. PubMed ID: 16612389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designed peptide analogues of the potassium channel blocker ShK toxin.
    Lanigan MD; Pennington MW; Lefievre Y; Rauer H; Norton RS
    Biochemistry; 2001 Dec; 40(51):15528-37. PubMed ID: 11747428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel.
    Nekrasova OV; Volyntseva AD; Kudryashova KS; Novoseletsky VN; Lyapina EA; Illarionova AV; Yakimov SA; Korolkova YV; Shaitan KV; Kirpichnikov MP; Feofanov AV
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):260-276. PubMed ID: 27640211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile.
    Middleton RE; Sanchez M; Linde AR; Bugianesi RM; Dai G; Felix JP; Koprak SL; Staruch MJ; Bruguera M; Cox R; Ghosh A; Hwang J; Jones S; Kohler M; Slaughter RS; McManus OB; Kaczorowski GJ; Garcia ML
    Biochemistry; 2003 Nov; 42(46):13698-707. PubMed ID: 14622016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin.
    Meng L; Xie Z; Zhang Q; Li Y; Yang F; Chen Z; Li W; Cao Z; Wu Y
    J Biol Chem; 2016 Mar; 291(13):7097-106. PubMed ID: 26817841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3.
    Lanigan MD; Kalman K; Lefievre Y; Pennington MW; Chandy KG; Norton RS
    Biochemistry; 2002 Oct; 41(40):11963-71. PubMed ID: 12356296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational exchange in the potassium channel blocker ShK.
    Iwakawa N; Baxter NJ; Wai DCC; Fowler NJ; Morales RAV; Sugase K; Norton RS; Williamson MP
    Sci Rep; 2019 Dec; 9(1):19307. PubMed ID: 31848433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
    Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
    FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
    Legros C; Schulze C; Garcia ML; Bougis PE; Martin-Eauclaire MF; Pongs O
    Biochemistry; 2002 Dec; 41(51):15369-75. PubMed ID: 12484776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new potassium channel toxin from the sea anemone Heteractis magnifica: isolation, cDNA cloning, and functional expression.
    Gendeh GS; Young LC; de Medeiros CL; Jeyaseelan K; Harvey AL; Chung MC
    Biochemistry; 1997 Sep; 36(38):11461-71. PubMed ID: 9298966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties.
    Peigneur S; Billen B; Derua R; Waelkens E; Debaveye S; Béress L; Tytgat J
    Biochem Pharmacol; 2011 Jul; 82(1):81-90. PubMed ID: 21477583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AbeTx1 Is a Novel Sea Anemone Toxin with a Dual Mechanism of Action on Shaker-Type K⁺ Channels Activation.
    B Orts DJ; Peigneur S; Silva-Gonçalves LC; Arcisio-Miranda M; P W Bicudo JE; Tytgat J
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30275388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.